The last study found that several selected radiomic features could effectively divide gliomas into two survival-related subgroups, where the subgroup with superior survival and lower malignancy-rate, had a higher probability of IDH-mutation [22]. This evidence concerns the gene IDH1 and central nervous system cancer.